{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:25:38Z","timestamp":1788884738131,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL142770"],"award-info":[{"award-number":["R01 HL142770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL1532654"],"award-info":[{"award-number":["R01HL1532654"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL1532654"],"award-info":[{"award-number":["R01HL1532654"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX003271"],"award-info":[{"award-number":["I01BX003271"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aging of the vasculature is characterized by endothelial dysfunction and arterial stiffening, two key events in the pathogenesis of cardiovascular disease (CVD). Treatment with sodium glucose transporter 2 (SGLT2) inhibitors is now known to decrease cardiovascular morbidity and mortality in type 2 diabetes. However, whether SGLT2 inhibition attenuates vascular aging is unknown. We first confirmed in a cohort of adult subjects that aging is associated with impaired endothelial function and increased arterial stiffness and that these two variables are inversely correlated. Next, we investigated whether SGLT2 inhibition with empagliflozin (Empa) ameliorates endothelial dysfunction and reduces arterial stiffness in aged mice with confirmed vascular dysfunction. Specifically, we assessed mesenteric artery endothelial function and stiffness (via flow-mediated dilation and pressure myography mechanical responses, respectively) and aortic stiffness (in vivo via pulse wave velocity and ex vivo via atomic force microscopy) in Empa-treated (14\u00a0mg\/kg\/day for 6\u00a0weeks) and control 80-week-old C57BL\/6\u00a0J male mice. We report that Empa-treated mice exhibited improved mesenteric endothelial function compared with control, in parallel with reduced mesenteric artery and aortic stiffness. Additionally, Empa-treated mice had greater vascular endothelial nitric oxide synthase activation, lower phosphorylated cofilin, and filamentous actin content, with downregulation of pathways involved in production of reactive oxygen species. Our findings demonstrate that Empa improves endothelial function and reduces arterial stiffness in a preclinical model of aging, making SGLT2 inhibition a potential therapeutic alternative to reduce the progression of CVD in older individuals.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s11357-022-00563-x","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T06:02:35Z","timestamp":1650002555000},"page":"1657-1675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["SGLT2 inhibition attenuates arterial dysfunction and decreases vascular F-actin content and expression of proteins associated with oxidative stress in aged mice"],"prefix":"10.1007","volume":"44","author":[{"given":"Rogerio N.","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco I.","family":"Ramirez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Cabral-Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Morales-Quinones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaysa","family":"Ghiarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neekun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Rector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Martinez-Lemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-404X","authenticated-orcid":false,"given":"Camila","family":"Manrique-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"issue":"12","key":"563_CR1","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/jamacardio.2019.4187","volume":"4","author":"S Sidney","year":"2019","unstructured":"Sidney S, Go AS, Jaffe MG, Solomon MD, Ambrosy AP, Rana JS. Association between aging of the US population and heart disease mortality from 2011 to 2017. JAMA Cardiol. 2019;4(12):1280\u20136.","journal-title":"JAMA Cardiol"},{"issue":"12","key":"563_CR2","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1152\/japplphysiol.00521.2018","volume":"125","author":"MJ Rossman","year":"2018","unstructured":"Rossman MJ, LaRocca TJ, Martens CR, Seals DR. Healthy lifestyle-based approaches for successful vascular aging. J Appl Physiol. 2018;125(12):1888\u2013900.","journal-title":"J Appl Physiol"},{"issue":"2","key":"563_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12551-017-0255-9","volume":"9","author":"M Steenman","year":"2017","unstructured":"Steenman M, Lande G. Cardiac aging and heart disease in humans. Biophys Rev. 2017;9(2):131\u20137.","journal-title":"Biophys Rev"},{"issue":"8","key":"563_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacc.2019.11.061","volume":"75","author":"Z Ungvari","year":"2020","unstructured":"Ungvari Z, Tarantini S, Sorond F, Merkely B, Csiszar A. Mechanisms of vascular aging, a geroscience perspective. J Am Coll Cardiol. 2020;75(8):931\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"563_CR5","unstructured":"Lacolley P, Regnault V, Avolio AP. Smooth muscle cell and arterial aging: basic and clinical aspects. (1755\u20133245 (Electronic))."},{"issue":"3","key":"563_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/agm2.12049","volume":"1","author":"C Zhang","year":"2018","unstructured":"Zhang C, Tao L, Cardiovascular Group SoG. Chinese Medical Association Expert consensus on clinical assessment and intervention of vascular aging in China. Aging Medicine. 2018;1(3):228\u201337.","journal-title":"Aging Medicine"},{"issue":"5","key":"563_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.14336\/AD.2017.0430","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Wang B, Ren C, Hu J, Greenberg DA, Chen T, et al. Age-related impairment of vascular structure and functions. Aging Dis. 2017;8(5):590.","journal-title":"Aging Dis"},{"issue":"4","key":"563_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00421-007-0447-2","volume":"100","author":"DP Casey","year":"2007","unstructured":"Casey DP, Pierce GL, Howe KS, Mering MC, Braith RW. Effect of resistance training on arterial wave reflection and brachial artery reactivity in normotensive postmenopausal women. Eur J Appl Physiol. 2007;100(4):403\u20138.","journal-title":"Eur J Appl Physiol"},{"issue":"1","key":"563_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/CS20100174","volume":"120","author":"GL Pierce","year":"2011","unstructured":"Pierce GL, Eskurza I, Walker AE, Fay TN, Seals DR. Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults. Clin Sci. 2011;120(1):13\u201323.","journal-title":"Clin Sci"},{"issue":"7","key":"563_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/BF02982710","volume":"12","author":"S Miller","year":"2008","unstructured":"Miller S, Wolfe RR. The danger of weight loss in the elderly. J Nutr Health Aging. 2008;12(7):487\u201391.","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"563_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","volume":"6","author":"DK McGuire","year":"2021","unstructured":"McGuire DK, Shih WJ, Cosentino F, Charbonnel B, Cherney DZI, Dagogo-Jack S, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiology. 2021;6(2):148\u201358.","journal-title":"JAMA Cardiology"},{"key":"563_CR12","doi-asserted-by":"crossref","unstructured":"Cardoso R, Graffunder FP, Ternes CM, Fernandes A, Rocha AV, Fernandes G, et al. SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis. EClinicalMedicine. 2021:100933.","DOI":"10.1016\/j.eclinm.2021.100933"},{"issue":"3","key":"563_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10741-017-9665-9","volume":"23","author":"A Kaplan","year":"2018","unstructured":"Kaplan A, Abidi E, El-Yazbi A, Eid A, Booz GW, Zouein FA. Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects. Heart Fail Rev. 2018;23(3):419\u201337.","journal-title":"Heart Fail Rev"},{"key":"563_CR14","unstructured":"Bailey CJ. Renal glucose reabsorption inhibitors to treat diabetes. (1873\u20133735 (Electronic))."},{"issue":"10","key":"563_CR15","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.2337\/db13-0604","volume":"62","author":"MA Abdul-Ghani","year":"2013","unstructured":"Abdul-Ghani MA, DeFronzo RA, Norton L. Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30\u201350% of filtered glucose load in humans. Diabetes. 2013;62(10):3324.","journal-title":"Diabetes"},{"issue":"22","key":"563_CR16","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"15","key":"563_CR17","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","volume":"73","author":"G Santos-Gallego Carlos","year":"2019","unstructured":"Santos-Gallego Carlos G, Requena-Ibanez Juan A, San Antonio R, Ishikawa K, Watanabe S, Picatoste B, et al. Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics. J Am Coll Cardiol. 2019;73(15):1931\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"563_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"MDCA Lopez","year":"2020","unstructured":"Lopez MDCA, Lax A, Vicente AH, Guillen ES, Hernandez-Martinez A, Del Palacio MJF, et al. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020;10(1):1\u201314.","journal-title":"Sci Rep"},{"issue":"8","key":"563_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00125-017-4301-8","volume":"60","author":"GP Fadini","year":"2017","unstructured":"Fadini GP, Bonora BM, Avogaro A. SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System. Diabetologia. 2017;60(8):1385\u20139.","journal-title":"Diabetologia"},{"issue":"3","key":"563_CR20","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1210\/jc.2011-2260","volume":"97","author":"J Bolinder","year":"2012","unstructured":"Bolinder J, Ljunggren \u00d6, Kullberg J, Johansson L, Wilding J, Langkilde AM, et al. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. J Clin Endocrinol Metab. 2012;97(3):1020\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"563_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jash.2014.02.003","volume":"8","author":"RV Oliva","year":"2014","unstructured":"Oliva RV, Bakris GL. Blood pressure effects of sodium\u2013glucose co-transport 2 (SGLT2) inhibitors. J Am Soc Hypertens. 2014;8(5):330\u20139.","journal-title":"J Am Soc Hypertens"},{"issue":"9","key":"563_CR22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/dom.12127","volume":"15","author":"H Lambers Heerspink","year":"2013","unstructured":"Lambers Heerspink H, De Zeeuw D, Leslie B, List J. Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab. 2013;15(9):853\u201362.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"563_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2337\/dc17-1096","volume":"41","author":"SE Inzucchi","year":"2018","unstructured":"Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, et al. How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA-REG OUTCOME trial. Diabetes Care. 2018;41(2):356\u201363.","journal-title":"Diabetes Care"},{"issue":"12","key":"563_CR24","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/dom.12572","volume":"17","author":"R Chilton","year":"2015","unstructured":"Chilton R, Tikkanen I, Cannon C, Crowe S, Woerle H, Broedl U, et al. Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obes Metab. 2015;17(12):1180\u201393.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"563_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","volume":"3","author":"S Verma","year":"2018","unstructured":"Verma S, Rawat S, Ho KL, Wagg CS, Zhang L, Teoh H, et al. Empagliflozin increases cardiac energy&#xa0 Production&#xa0 in diabetes. JACC Basic to Trans Sci. 2018;3(5):575\u201387.","journal-title":"JACC Basic to Trans Sci"},{"key":"563_CR26","doi-asserted-by":"crossref","unstructured":"Park LK, Parks EJ, Pettit-Mee RJ, Woodford ML, Ghiarone T, Smith JA, et al. Skeletal muscle microvascular insulin resistance in type 2 diabetes is not improved by eight weeks of regular walking. J Appl Physiol (1985). 2020.","DOI":"10.1152\/japplphysiol.00174.2020"},{"issue":"1","key":"563_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1152\/japplphysiol.00001.2017","volume":"123","author":"AL Teixeira","year":"2017","unstructured":"Teixeira AL, Padilla J, Vianna LC. Impaired popliteal artery flow-mediated dilation caused by reduced daily physical activity is prevented by increased shear stress. J Appl Physiol. 2017;123(1):49\u201354.","journal-title":"J Appl Physiol"},{"issue":"30","key":"563_CR28","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"Thijssen DHJ, Bruno RM, van Mil A, Holder SM, Faita F, Greyling A, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40(30):2534\u201347.","journal-title":"Eur Heart J"},{"issue":"4","key":"563_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.120.15262","volume":"76","author":"ZI Grunewald","year":"2020","unstructured":"Grunewald ZI, Ramirez-Perez FI, Woodford ML, Morales-Quinones M, Mejia S, Manrique-Acevedo C, et al. TRAF3IP2 (TRAF3 interacting protein 2) mediates obesity-associated vascular insulin resistance and dysfunction in male mice. Hypertension. 2020;76(4):1319\u201329.","journal-title":"Hypertension"},{"issue":"2","key":"563_CR30","doi-asserted-by":"publisher","first-page":"H435","DOI":"10.1152\/ajpheart.00076.2021","volume":"321","author":"FI Ramirez-Perez","year":"2021","unstructured":"Ramirez-Perez FI, Woodford ML, Morales-Quinones M, Grunewald ZI, Cabral-Amador FJ, Yoshida T, et al. Mutation of the 5\u2032-untranslated region stem-loop mRNA structure reduces type I collagen deposition and arterial stiffness in male obese mice. Am J Physiol-Heart Circ Physiol. 2021;321(2):H435\u201345.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"12","key":"563_CR31","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1210\/en.2019-00483","volume":"160","author":"J Padilla","year":"2019","unstructured":"Padilla J, Woodford ML, Lastra-Gonzalez G, Martinez-Diaz V, Fujie S, Yang Y, et al. Sexual dimorphism in obesity-associated endothelial ENaC activity and stiffening in mice. Endocrinology. 2019;160(12):2918\u201328.","journal-title":"Endocrinology"},{"key":"563_CR32","doi-asserted-by":"crossref","unstructured":"Jia G, Habibi J, Aroor AR, Martinez-Lemus LA, DeMarco VG, Ramirez-Perez FI, et al. Endothelial mineralocorticoid receptor mediates diet induced aortic stiffness in females. Circ Res. 2016.","DOI":"10.1161\/CIRCRESAHA.115.308269"},{"issue":"1","key":"563_CR33","doi-asserted-by":"publisher","first-page":"H77","DOI":"10.1152\/ajpheart.01021.2020","volume":"321","author":"CF Wenceslau","year":"2021","unstructured":"Wenceslau CF, McCarthy CG, Earley S, England SK, Filosa JA, Goulopoulou S, et al. Guidelines for the measurement of vascular function and structure in isolated arteries and veins. Am J Physiol Heart Circ Physiol. 2021;321(1):H77-h111.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"563_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"issue":"8","key":"563_CR35","doi-asserted-by":"publisher","first-page":"R744","DOI":"10.1152\/ajpregu.00473.2015","volume":"310","author":"TJ Jurrissen","year":"2016","unstructured":"Jurrissen TJ, Sheldon RD, Gastecki ML, Woodford ML, Zidon TM, Rector RS, et al. Ablation of eNOS does not promote adipose tissue inflammation. Am J Physiol Regul Integr Comp Physiol. 2016;310(8):R744\u201351.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"11","key":"563_CR36","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.2337\/db20-1228","volume":"70","author":"RP Cunningham","year":"2021","unstructured":"Cunningham RP, Moore MP, Dashek RJ, Meers GM, Takahashi T, Sheldon RD, et al. Critical role for hepatocyte-specific eNOS in NAFLD and NASH. Diabetes. 2021;70(11):2476\u201391.","journal-title":"Diabetes"},{"key":"563_CR37","first-page":"1","volume":"9","author":"B Bull","year":"2003","unstructured":"Bull B, Fujimoto K, Houwen B, Klee G, Van Hove L, Van Assendelft O, et al. International Council for Standardization in Haematology (ICSH) recommendations for\" surrogate reference\" method for the packed cell volume. Lab Hematol. 2003;9:1\u20139.","journal-title":"Lab Hematol"},{"issue":"6","key":"563_CR38","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/01.HYP.0000128420.01881.aa","volume":"43","author":"GF Mitchell","year":"2004","unstructured":"Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004;43(6):1239\u201345.","journal-title":"Hypertension"},{"issue":"9","key":"563_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/CS20100476","volume":"120","author":"DR Seals","year":"2011","unstructured":"Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond). 2011;120(9):357\u201375.","journal-title":"Clin Sci (Lond)"},{"issue":"18","key":"563_CR40","doi-asserted-by":"publisher","first-page":"e012670","DOI":"10.1161\/JAHA.119.012670","volume":"8","author":"J Majerczak","year":"2019","unstructured":"Majerczak J, Grandys M, Fro\u0142ow M, Szkutnik Z, Zakrzewska A, Ni\u017cankowski R, et al. Age\u2010Dependent impairment in endothelial function and arterial stiffness in former high class male athletes is no different to that in men with no history of physical training. Journal of the American Heart Association. 2019;8(18):e012670.","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"563_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2003.10.013","volume":"173","author":"K Kobayashi","year":"2004","unstructured":"Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis. 2004;173(1):13\u20138.","journal-title":"Atherosclerosis"},{"key":"563_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijcard.2017.11.022","volume":"253","author":"H Tomiyama","year":"2018","unstructured":"Tomiyama H, Ishizu T, Kohro T, Matsumoto C, Higashi Y, Takase B, et al. Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension. Int J Cardiol. 2018;253:161\u20136.","journal-title":"Int J Cardiol"},{"issue":"2","key":"563_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0021-9150(02)00332-5","volume":"166","author":"H Tomiyama","year":"2003","unstructured":"Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement\u2013a survey of 12517 subjects. Atherosclerosis. 2003;166(2):303\u20139.","journal-title":"Atherosclerosis"},{"key":"563_CR44","unstructured":"Nicholson CJ, Singh K, Saphirstein RJ, Gao YZ, Li Q, Chiu JG, et al. Reversal of aging\u2010induced increases in aortic stiffness by targeting cytoskeletal protein\u2010protein interfaces. Journal of the American Heart Association. 2018;7(15):e008926."},{"issue":"6","key":"563_CR45","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.amjhyper.2007.01.008","volume":"20","author":"M Vyas","year":"2007","unstructured":"Vyas M, Izzo JL, Lacourci\u00e8re Y, Arnold JMO, Dunlap ME, Amato JL, et al. Augmentation index and central aortic stiffness in middle-aged to elderly individuals*. Am J Hypertens. 2007;20(6):642\u20137.","journal-title":"Am J Hypertens"},{"issue":"5","key":"563_CR46","doi-asserted-by":"publisher","first-page":"e12015","DOI":"10.14814\/phy2.12015","volume":"2","author":"J Ohanian","year":"2014","unstructured":"Ohanian J, Liao A, Forman SP, Ohanian V. Age-related remodeling of small arteries is accompanied by increased sphingomyelinase activity and accumulation of long-chain ceramides. Physiol Rep. 2014;2(5):e12015.","journal-title":"Physiol Rep"},{"key":"563_CR47","doi-asserted-by":"crossref","unstructured":"Xu J, Huang Y, Zhao J, Wu L, Qi Q, Liu Y, et al. Cofilin: a promising protein implicated in cancer metastasis and apoptosis. Frontiers in Cell and Developmental Biology. 2021;9(55).","DOI":"10.3389\/fcell.2021.599065"},{"issue":"2","key":"563_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0008-6363(98)00074-1","volume":"39","author":"SK Samijo","year":"1998","unstructured":"Samijo SK, Willigers JM, Barkhuysen R, Kitslaar PJEHM, Reneman RS, Brands PJ, et al. Wall shear stress in the human common carotid artery as function of age and gender. Cardiovasc Res. 1998;39(2):515\u201322.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"563_CR49","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1161\/01.ATV.19.10.2298","volume":"19","author":"H Masuda","year":"1999","unstructured":"Masuda H, Zhuang Y-J, Singh TM, Kawamura K, Murakami M, Zarins CK, et al. Adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement. Arterioscler Thromb Vasc Biol. 1999;19(10):2298\u2013307.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"563_CR50","doi-asserted-by":"publisher","first-page":"H851","DOI":"10.1152\/ajpheart.1997.272.2.H851","volume":"272","author":"AB Driss","year":"1997","unstructured":"Driss AB, Benessiano J, Poitevin P, Levy BI, Michel JB. Arterial expansive remodeling induced by high flow rates. Am J Physiol-Heart Circ Physiol. 1997;272(2):H851\u20138.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"3","key":"563_CR51","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/CIRCRESAHA.119.315644","volume":"126","author":"DJ Tyrrell","year":"2020","unstructured":"Tyrrell DJ, Blin MG, Song J, Wood SC, Zhang M, Beard DA, et al. Age-associated mitochondrial dysfunction accelerates atherogenesis. Circ Res. 2020;126(3):298\u2013314.","journal-title":"Circ Res"},{"key":"563_CR52","doi-asserted-by":"crossref","unstructured":"Newaz MA, Yousefipour Z, Oyekan A. Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent. Journal of Cardiovascular Pharmacology. 2006;48(3).","DOI":"10.1097\/01.fjc.0000245402.62864.0a"},{"key":"563_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.yjmcc.2016.12.004","volume":"102","author":"A Lozhkin","year":"2017","unstructured":"Lozhkin A, Vendrov AE, Pan H, Wickline SA, Madamanchi NR, Runge MS. NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis. J Mol Cell Cardiol. 2017;102:10\u201321.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"563_CR54","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.01445","volume":"62","author":"M AlGhatrif","year":"2013","unstructured":"AlGhatrif M, Strait JB, Morrell CH, Canepa M, Wright J, Elango P, et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension. 2013;62(5):934\u201341.","journal-title":"Hypertension"},{"key":"563_CR55","doi-asserted-by":"crossref","unstructured":"Anderson TJ. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol. 2006;22 Suppl B(Suppl B):72B-80B.","DOI":"10.1016\/S0828-282X(06)70990-4"},{"issue":"6","key":"563_CR56","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00125-012-2517-1","volume":"55","author":"RM Bruno","year":"2012","unstructured":"Bruno RM, Penno G, Daniele G, Pucci L, Lucchesi D, Stea F, et al. Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia. 2012;55(6):1847\u201355.","journal-title":"Diabetologia"},{"issue":"9","key":"563_CR57","doi-asserted-by":"publisher","first-page":"e015716","DOI":"10.1161\/JAHA.119.015716","volume":"9","author":"I Ikonomidis","year":"2020","unstructured":"Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, et al. Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx arterial function and myocardial work index in patients with type 2 diabetes Mellitus After 12-Month Treatment. J Am Heart Assoc. 2020;9(9):e015716.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"563_CR58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","volume":"9","author":"JA Requena-Ib\u00e1\u00f1ez","year":"2021","unstructured":"Requena-Ib\u00e1\u00f1ez JA, Santos-Gallego CG, Rodriguez-Cordero A, Vargas-Delgado AP, Mancini D, Sartori S, et al. Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study. JACC Heart Fail. 2021;9(8):578\u201389.","journal-title":"JACC Heart Fail"},{"issue":"12","key":"563_CR59","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.117.029529","volume":"136","author":"K Striepe","year":"2017","unstructured":"Striepe K, Jumar A, Ott C, Karg MV, Schneider MP, Kannenkeril D, et al. Effects of the selective sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function and central hemodynamics in patients with type 2 diabetes Mellitus. Circulation. 2017;136(12):1167\u20139.","journal-title":"Circulation"},{"issue":"6809","key":"563_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/35041687","volume":"408","author":"T Finkel","year":"2000","unstructured":"Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239\u201347.","journal-title":"Nature"},{"issue":"1","key":"563_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/CS20100174","volume":"120","author":"GL Pierce","year":"2011","unstructured":"Pierce GL, Eskurza I, Walker AE, Fay TN, Seals DR. Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults. Clin Sci (Lond). 2011;120(1):13\u201323.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"563_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2011.04.033","volume":"218","author":"RS Patel","year":"2011","unstructured":"Patel RS, Al Mheid I, Morris AA, Ahmed Y, Kavtaradze N, Ali S, et al. Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis. 2011;218(1):90\u20135.","journal-title":"Atherosclerosis"},{"issue":"9","key":"563_CR63","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.amjhyper.2006.02.003","volume":"19","author":"J Kals","year":"2006","unstructured":"Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, et al. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens. 2006;19(9):902\u20138.","journal-title":"Am J Hypertens"},{"key":"563_CR64","doi-asserted-by":"crossref","unstructured":"Rossman MJ, Santos-Parker JR, Steward CAC, Bispham NZ, Cuevas LM, Rosenberg HL, et al. chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension. 2018.","DOI":"10.1096\/fasebj.2018.32.1_supplement.845.8"},{"issue":"1","key":"563_CR65","doi-asserted-by":"publisher","first-page":"14659","DOI":"10.1038\/s41598-020-71599-2","volume":"10","author":"R Hasan","year":"2020","unstructured":"Hasan R, Lasker S, Hasan A, Zerin F, Zamila M, Parvez F, et al. Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK-Akt-eNOS pathway in the isoprenaline-induced oxidative stress model. Sci Rep. 2020;10(1):14659.","journal-title":"Sci Rep"},{"issue":"1","key":"563_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Xue M, Li X, Han F, Liu X, et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol. 2019;18(1):15.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"563_CR67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12933-018-0750-8","volume":"17","author":"AR Aroor","year":"2018","unstructured":"Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, et al. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. Cardiovasc Diabetol. 2018;17(1):108.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"563_CR68","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-017-0621-8","volume":"16","author":"A Solini","year":"2017","unstructured":"Solini A, Giannini L, Seghieri M, Vitolo E, Taddei S, Ghiadoni L, et al. Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study. Cardiovasc Diabetol. 2017;16(1):138.","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"563_CR69","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1111\/j.1742-4658.2008.06489.x","volume":"275","author":"T Nishino","year":"2008","unstructured":"Nishino T, Okamoto K, Eger BT, Pai EF, Nishino T. Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. Febs j. 2008;275(13):3278\u201389.","journal-title":"Febs j"},{"issue":"3","key":"563_CR70","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1172\/JCI64125","volume":"123","author":"A Bratic","year":"2013","unstructured":"Bratic A, Larsson N-G. The role of mitochondria in aging. J Clin Investig. 2013;123(3):951\u20137.","journal-title":"J Clin Investig"},{"issue":"8","key":"563_CR71","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.111.246140","volume":"110","author":"D-F Dai","year":"2012","unstructured":"Dai D-F, Rabinovitch PS, Ungvari Z, Sinclair D, North B. Mitochondria and cardiovascular aging. Circ Res. 2012;110(8):1109\u201324.","journal-title":"Circ Res"},{"issue":"1","key":"563_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0695-y","volume":"17","author":"C Irace","year":"2018","unstructured":"Irace C, Casciaro F, Scavelli FB, Oliverio R, Cutruzzol\u00e0 A, Cortese C, et al. Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy. Cardiovasc Diabetol. 2018;17(1):1\u20139.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"563_CR73","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2213-8587(20)30382-X","volume":"9","author":"J Jensen","year":"2021","unstructured":"Jensen J, Omar M, Kistorp C, Tuxen C, Gustafsson I, K\u00f8ber L, et al. Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2021;9(2):106\u201316.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"563_CR74","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0895-7061(99)00011-4","volume":"12","author":"Y \u00c7\u0131nar","year":"1999","unstructured":"\u00c7\u0131nar Y, Demir G, Pa\u00e7 M, \u00c7\u0131nar AB. Effect of hematocrit on blood pressure via hyperviscosity. Am J Hypertens. 1999;12(7):739\u201343.","journal-title":"Am J Hypertens"},{"issue":"3","key":"563_CR75","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.medengphy.2014.12.011","volume":"37","author":"J Lantz","year":"2015","unstructured":"Lantz J, Renner J, L\u00e4nne T, Karlsson M. Is aortic wall shear stress affected by aging? An image-based numerical study with two age groups. Med Eng Phys. 2015;37(3):265\u201371.","journal-title":"Med Eng Phys"},{"issue":"1","key":"563_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MNH.0000000000000092","volume":"24","author":"GF Mitchell","year":"2015","unstructured":"Mitchell GF. Arterial stiffness: insights from Framingham and Iceland. Curr Opin Nephrol Hypertens. 2015;24(1):1\u20137.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"563_CR77","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ajh\/hpu206","volume":"28","author":"ME Safar","year":"2015","unstructured":"Safar ME, Plante GE, Mimran A. Arterial stiffness, pulse pressure, and the kidney. Am J Hypertens. 2015;28(5):561\u20139.","journal-title":"Am J Hypertens"},{"key":"563_CR78","doi-asserted-by":"crossref","unstructured":"Bonarjee VVS. Arterial stiffness: a prognostic marker in coronary heart disease. Available Methods and Clinical Application. Frontiers in Cardiovascular Medicine. 2018;5(64).","DOI":"10.3389\/fcvm.2018.00064"},{"issue":"4","key":"563_CR79","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/cvr\/cvy009","volume":"114","author":"P Lacolley","year":"2018","unstructured":"Lacolley P, Regnault V, Avolio AP. Smooth muscle cell and arterial aging: basic and clinical aspects. Cardiovasc Res. 2018;114(4):513\u201328.","journal-title":"Cardiovasc Res"},{"key":"563_CR80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fphys.2015.00335","volume":"6","author":"NL Sehgel","year":"2015","unstructured":"Sehgel NL, Vatner SF, Meininger GA. \u201cSmooth muscle cell stiffness syndrome\u201d-revisiting the structural basis of arterial stiffness. Front Physiol. 2015;6:335.","journal-title":"Front Physiol"},{"issue":"1","key":"563_CR81","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1038\/s41598-018-20763-w","volume":"8","author":"W Zhu","year":"2018","unstructured":"Zhu W, Kim BC, Wang M, Huang J, Isak A, Bexiga NM, et al. TGF\u03b21 reinforces arterial aging in the vascular smooth muscle cell through a long-range regulation of the cytoskeletal stiffness. Sci Rep. 2018;8(1):2668.","journal-title":"Sci Rep"},{"issue":"2","key":"563_CR82","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.120.15203","volume":"76","author":"M Morales-Quinones","year":"2020","unstructured":"Morales-Quinones M, Ramirez-Perez FI, Foote CA, Ghiarone T, Ferreira-Santos L, Bloksgaard M, et al. LIMK (LIM kinase) inhibition prevents vasoconstriction- and hypertension-induced arterial stiffening and remodeling. Hypertension. 2020;76(2):393\u2013403.","journal-title":"Hypertension"},{"issue":"3","key":"563_CR83","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.immuni.2008.06.016","volume":"29","author":"M Klemke","year":"2008","unstructured":"Klemke M, Wabnitz GH, Funke F, Funk B, Kirchgessner H, Samstag Y. Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity. 2008;29(3):404\u201313.","journal-title":"Immunity"},{"issue":"1","key":"563_CR84","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imr.12115","volume":"256","author":"Y Samstag","year":"2013","unstructured":"Samstag Y, John I, Wabnitz GH. Cofilin: a redox sensitive mediator of actin dynamics during T-cell activation and migration. Immunol Rev. 2013;256(1):30\u201347.","journal-title":"Immunol Rev"},{"issue":"7","key":"563_CR85","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MCG.0b013e31825692ce","volume":"46","author":"EM Mathus-Vliegen","year":"2012","unstructured":"Mathus-Vliegen EM. Obesity and the elderly. J Clin Gastroenterol. 2012;46(7):533\u201344.","journal-title":"J Clin Gastroenterol"},{"key":"563_CR86","first-page":"1","volume":"360","author":"CM Hales","year":"2020","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief. 2020;360:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"3","key":"563_CR87","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00421-013-2684-x","volume":"114","author":"J Padilla","year":"2014","unstructured":"Padilla J, Jenkins NT, Laughlin MH, Fadel PJ. Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype. Eur J Appl Physiol. 2014;114(3):531\u201344.","journal-title":"Eur J Appl Physiol"},{"key":"563_CR88","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13293-016-0110-x","volume":"7","author":"G Barsha","year":"2016","unstructured":"Barsha G, Denton KM, Mirabito Colafella KM. Sex- and age-related differences in arterial pressure and albuminuria in mice. Biol Sex Differ. 2016;7:57.","journal-title":"Biol Sex Differ"},{"issue":"6","key":"563_CR89","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1161\/HYP.0000000000000090","volume":"73","author":"LO Lerman","year":"2019","unstructured":"Lerman LO, Kurtz TW, Touyz RM, Ellison DH, Chade AR, Crowley SD, et al. Animal models of hypertension: a scientific statement from the American Heart Association. Hypertension. 2019;73(6):e87\u2013120.","journal-title":"Hypertension"},{"issue":"2","key":"563_CR90","doi-asserted-by":"publisher","first-page":"e14360","DOI":"10.14814\/phy2.14360","volume":"8","author":"T Masuda","year":"2020","unstructured":"Masuda T, Muto S, Fukuda K, Watanabe M, Ohara K, Koepsell H, et al. Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume. Physiol Rep. 2020;8(2):e14360.","journal-title":"Physiol Rep"},{"issue":"3","key":"563_CR91","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2337\/dc13-2955","volume":"38","author":"RR Henry","year":"2015","unstructured":"Henry RR, Rosenstock J, Edelman S, Mudaliar S, Chalamandaris AG, Kasichayanula S, et al. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2015;38(3):412\u20139.","journal-title":"Diabetes Care"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-022-00563-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T11:25:28Z","timestamp":1666524328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-022-00563-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1007\/s11357-022-00563-x","relation":{},"ISSN":["2509-2715","2509-2723"],"issn-type":[{"value":"2509-2715","type":"print"},{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures performed in \u00a0were approved by the University of Missouri Institutional Review Board (protocols #2012990, #2028142, and #2012869) and conducted following the Declaration of Helsinki. All animal procedures were performed in accordance with the Animal Use and Care Committee at the University of Missouri in Columbia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants prior to participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}